Murray Berlin.25.11.04 - Final presentation - vfa.de · partnership with WHO in the Global...

26
Insufficiencies in healthcare systems Actions by research-based pharmaceutical industry Christopher Murray Director, Pharma International, Roche Roche Principal to the Accelerating Access Initiative VFA Berlin 25/11/04

Transcript of Murray Berlin.25.11.04 - Final presentation - vfa.de · partnership with WHO in the Global...

Insu

ffici

enci

es in

hea

lthca

re s

yste

ms

Act

ions

by

rese

arch

-bas

ed p

harm

aceu

tical

in

dust

ry

Chr

isto

pher

Mur

ray

Dire

ctor

, Pha

rma

Inte

rnat

iona

l, R

oche

Roc

he P

rinci

pal t

o th

e A

ccel

erat

ing

Acc

ess

Initi

ativ

e

VFA

Ber

lin 2

5/11

/04

Ove

rvie

w

•H

ealth

care

cha

lleng

es a

cros

s lo

w in

com

e co

untri

es

•S

ocia

lly re

spon

sibl

e ac

tion

by th

e re

sear

ch-

base

d P

harm

aceu

tical

Indu

stry

–w

hy, h

ow?

•E

xam

ples

dem

onst

ratin

g P

rivat

e P

ublic

P

artn

ersh

ips

by th

e re

sear

ch-b

ased

P

harm

aceu

tical

Indu

stry

•Fu

ture

cha

lleng

es

WH

O u

rges

sci

ence

to k

eep

wor

ld

heal

thy

(10/

11/0

4)

•“H

alf t

he w

orld

's d

isea

ses

can

be p

reve

nted

by

sim

ple

mea

ns a

lread

y av

aila

ble,

…”

•“In

Afri

ca,…

it is

est

imat

ed th

at o

nly

betw

een

2-15

% o

f chi

ldre

n sl

ept u

nder

bed

-net

s in

200

1-a

sim

ple,

effe

ctiv

e an

d pr

oven

met

hod

to p

reve

nt

mal

aria

. “

Exam

ples

of h

ealth

care

cha

lleng

es

acro

ss lo

w in

com

e co

untr

ies

•P

over

ty /

Fund

ing

–3

billio

n pe

ople

live

on

< $2

/ da

y, h

ealth

care

is u

naffo

rdab

le–

heal

thca

re fu

ndin

g

•S

ocia

l and

cul

tura

l fac

tors

impa

ctin

g he

alth

stig

ma

of d

isea

ses

such

as

HIV

/AID

S p

reve

nt te

stin

g an

d tre

atm

ent

–un

equa

l sta

tus

of w

omen

•P

oliti

cal w

ill–

egta

xes

levi

ed o

n es

sent

ial H

IV m

edic

ines

by

som

e go

vern

men

ts

•Fa

iling

hea

lthca

re s

yste

ms

–ed

ucat

ion,

trai

ning

, doc

tors

, nur

ses,

labo

rato

ry te

stin

g fa

cilit

ies,

se

cure

dru

g su

pply

cha

in–

600,

000

heal

th w

orke

rs in

sub

-Sah

aran

Afri

ca s

ervi

ng 6

82 m

illio

n pe

ople

, > 2

.5 m

illio

n ne

eded

(WH

O)

“AID

S ra

vage

d A

fric

a hi

t by

mas

s ex

odus

”Th

e D

aily

Tel

egra

ph 2

/11/

04

•“In

Gha

na a

nd Z

imba

bwe,

mor

e th

an 7

0% o

f do

ctor

s em

igra

te…

.”

•M

alaw

i –60

% n

ursi

ng p

ositi

ons

unfil

led

due

to

exod

us to

the

Wes

t

•“A

frica

's c

reak

ing

heal

th s

ervi

ces

are

clos

e to

co

llaps

e.”

Varia

tions

in H

ealth

Ex

pend

iture

s

•W

ide

varia

tions

in in

com

e le

vels

with

in a

nd

amon

g co

untri

es•

Gov

ernm

enta

l pol

icie

s an

d pr

iorit

ies

(US

$ pe

r cap

ita):

–B

otsw

ana

120,

Rus

sia

78–

Pak

ista

n 4,

Thai

land

39

–Li

beria

, 1V

ietn

am 6

–U

krai

ne 2

2,In

done

sia

4

•To

tal e

xpen

ditu

re o

n he

alth

as

% o

f GD

P

varie

s–

Sou

th A

frica

8%

Sen

egal

4.8

%

–M

adag

asca

r 2%

•H

ealth

exp

endi

ture

in lo

w in

com

e co

untri

es

deem

ed a

s fa

r fro

m s

uffic

ient

6

6. W

HO

. Com

mis

sion

on

Mac

roec

onom

ics

and

heat

h, 2

001

Soci

ally

resp

onsi

ble

actio

n by

the

Phar

mac

eutic

al In

dust

ry -

Why

?

•O

ur p

rimar

y ro

le:

–Th

e re

sear

ch-b

ased

pha

rmac

eutic

al in

dust

ry is

a u

niqu

e so

urce

of n

ew m

edic

ines

whi

ch h

ave

cont

inuo

usly

offe

red

clea

r be

nefit

s to

pat

ient

s, s

ocie

ties

and

heal

thca

re s

yste

ms

wor

ldw

ide

–R

esea

rch-

base

dph

arm

aceu

tical

com

pani

esha

vedi

scov

ered

and

deve

lope

dth

egr

eatm

ajor

ityof

exi

stin

gm

edic

ines

(ww

w.if

pma.

org)

•W

ith s

o m

any

broa

d ba

rrie

rs to

hea

lthca

re, c

lear

nee

d to

impr

ove

heal

th in

a s

usta

inab

le m

anne

r -ec

onom

ical

ly, s

ocia

lly a

nd e

nviro

nmen

tally

Soci

ally

resp

onsi

ble

actio

n by

the

Phar

mac

eutic

al In

dust

ry -

How

?

•C

orpo

rate

Gov

erna

nce

-act

ing

trans

pare

ntly

and

re

spon

sibl

y

•E

cono

mic

per

form

ance

-in

eve

ryon

e's

inte

rest

•S

afet

y an

d en

viro

nmen

tal p

rote

ctio

n

•E

ngag

emen

t and

dia

logu

e w

ith re

leva

nt s

take

hold

ers

•P

rivat

e P

ublic

Par

tner

ship

s

•In

divi

dual

and

col

lect

ive

com

pany

initi

ativ

es to

incr

ease

ac

cess

to h

ealth

care

and

med

icin

es

•H

IV/A

IDS

is n

ot “b

usin

ess

as u

sual

HIV

/AID

S is

not

“bu

sine

ss a

s us

ual”

•“T

o de

liver

ant

iretro

vira

l tre

atm

ent t

o th

e m

illio

ns w

ho

need

it, w

e m

ust c

hang

e th

e w

ay w

e th

ink

and

the

way

w

e ac

t.”

•“A

IDS

ther

apy

is a

long

-term

com

mitm

ent,

not a

one

sh

ot.

We

need

dra

mat

ic a

nd s

usta

ined

incr

ease

s in

re

sour

ce a

nd p

oliti

cal c

omm

itmen

t –in

clud

ing

from

the

hard

-hit

coun

tries

them

selv

es.”

Hea

d of

the

WH

O, D

r Jon

g-W

ook

Lee,

200

3

Kof

iAnn

anU

N S

ecre

tary

Gen

eral

Apr

il 20

01•

"The

pha

rmac

eutic

al in

dust

ry is

pla

ying

a c

ruci

al ro

le.

How

ever

, the

sol

utio

n do

es n

ot li

e w

ith th

e ph

arm

aceu

tical

com

pani

es a

lone

. I a

m c

allin

g fo

r a

maj

or m

obili

satio

n of

pol

itica

l will

and

sig

nific

ant

addi

tiona

l fun

ding

to e

nabl

e a

dram

atic

leap

forw

ard

in

prev

entio

n, e

duca

tion,

car

e an

d tre

atm

ent."

Wor

ld A

IDS

Day

mes

sage

, 200

3 •

“we

are

not o

n tra

ck to

beg

in re

duci

ng th

e sc

ale

and

impa

ct o

f the

epi

dem

ic b

y th

e ta

rget

yea

r of 2

005”

•“T

oday

, we

have

the

com

mitm

ent.

Our

reso

urce

s ar

e in

crea

sing

. But

the

actio

n is

stil

l far

sho

rt of

wha

t is

need

ed”

Priv

ate

Publ

ic P

artn

ersh

ips

Acc

eler

atin

g A

cces

s In

itiat

ive

(AA

I)

•A

nnou

nced

with

the

UN

May

200

0

•Th

e fir

st b

road

-bas

ed p

ublic

/priv

ate

partn

ersh

ip o

f its

ki

nd, e

stab

lishe

d to

:–

expa

nd th

e gl

obal

resp

onse

to H

IV/A

IDS

–fin

d su

stai

nabl

e ac

cess

to H

IV c

are

in re

sour

ce p

oor

coun

tries

dev

asta

ted

by H

IV/A

IDS

, par

ticul

arly

A

frica

•G

row

n to

incl

ude

7 ph

arm

aceu

tical

com

pani

es (A

bbot

t, B

MS

, BI,

GS

K, M

erck

, Gile

ad a

nd R

oche

) and

5 U

N

orga

nisa

tions

(UN

AID

S, W

HO

, UN

ICE

F, U

N P

opul

atio

n Fu

nd, a

nd th

e W

orld

Ban

k)

Acc

eler

atin

g A

cces

s In

itiat

ive

Prin

cipl

es

1.U

nequ

ivoc

al a

nd o

ngoi

ng p

oliti

cal c

omm

itmen

t by

natio

nal

gove

rnm

ents

2.S

treng

then

ed n

atio

nal c

apac

ity

3.E

ngag

emen

t of a

ll se

ctor

s of

nat

iona

l soc

iety

and

the

glob

al

com

mun

ity

4.E

ffici

ent,

relia

ble

and

secu

re d

istri

butio

n sy

stem

s

5.S

igni

fican

t add

ition

al fu

ndin

g fro

m n

ew s

ourc

es

6.C

ontin

ued

inve

stm

ent i

n re

sear

ch a

nd d

evel

opm

ent b

y th

e ph

arm

aceu

tical

indu

stry

HIV

can

rapi

dly

mut

ate

and

beco

me

resi

stan

t to

curr

ently

ava

ilabl

e m

edic

ines

Publ

ic p

artn

er v

iew

of A

AI p

rogr

ess

Mar

ch 0

4

“The

AA

I exp

erie

nce

show

s th

at w

ith p

oliti

cal w

ill,

com

mitm

ent a

nd p

artn

ersh

ip, i

t is

poss

ible

to

gene

rate

and

sus

tain

a la

rge

jum

p in

acc

ess

to

HIV

car

e an

d tre

atm

ent i

n re

sour

ce-c

onst

rain

ed

setti

ng”

Dr.

Jack

Cho

w, A

ssis

tant

Dire

ctor

-Gen

eral

of

the

Wor

ld H

ealth

Org

aniz

atio

n

How

are

rese

arch

-bas

ed p

harm

aceu

tical

co

mpa

nies

pla

ying

thei

r par

t in

the

solu

tion?

•C

ontin

ued

inve

stm

ent i

n re

sear

ch &

dev

elop

men

t for

to

mor

row

s A

IDS

dru

gs a

nd v

acci

nes

•In

200

3 -8

3 ne

w m

edic

ines

in d

evel

opm

ent f

or

HIV

/AID

S

•Th

ere

is n

o cu

re fo

r AID

S

•C

omm

ittin

g tim

e, e

nerg

y, m

illio

ns o

f dol

lars

and

hu

man

reso

urce

s to

sup

port

the

cons

truct

ion

of

func

tioni

ng h

ealth

care

sys

tem

s

•P

rovi

sion

of H

IV/A

IDS

trai

ning

and

edu

catio

n fo

r hu

ndre

ds o

f Afri

can

heal

thca

re p

rofe

ssio

nals

How

are

rese

arch

bas

ed p

harm

aceu

tical

co

mpa

nies

pla

ying

thei

r par

t in

the

solu

tion

? (2

)

•P

rice

and

pate

nt p

olic

ies

for A

RV

sac

ross

sub

-Sah

aran

A

frica

and

Lea

st D

evel

oped

Cou

ntrie

s -a

nnou

nced

by

indi

vidu

al c

ompa

nies

-m

ean

neith

er d

rug

pric

es n

or

pate

nts

can

be c

onsi

dere

d pr

imar

y ba

rrie

rs to

in

crea

sing

acc

ess

to H

IV th

erap

y

•R

esea

rch-

base

d co

mpa

nies

are

indi

vidu

ally

sup

plyi

ng

AR

Vs

to s

ub-S

ahar

an A

frica

at r

educ

ed p

rices

, som

e w

ithou

t pro

fit o

r fre

e of

cha

rge

•B

rand

ed A

RV

sca

n be

low

er c

ost t

han

gene

rics

(MS

F,

ww

w.a

cces

smed

-msf

.org

/pro

d/pu

blic

atio

ns)

Exam

ples

of p

harm

aceu

tical

com

pany

H

IV/A

IDS

part

ners

hips

and

initi

ativ

es

•M

erck

AC

HA

Ppa

rtner

ship

in B

otsw

ana

•B

MS

Sec

ure

the

futu

re p

rogr

amm

es

•A

bbot

t and

BI P

MTC

initi

ativ

e to

bot

h te

st a

nd

prev

ent H

IV tr

ansm

issi

on fr

om m

othe

r to

baby

•G

SK

Pos

itive

Act

ion

enco

mpa

sses

man

y in

itiat

ives

•G

ilead

acc

ess

prog

ram

me

invo

lvin

g go

vern

men

ts, N

GO

s, e

mpl

oyer

s an

d ho

spita

ls

Exam

ples

of p

harm

aceu

tical

co

mpa

ny in

itiat

ives

•Th

e M

erck

Mec

tizan

Don

atio

n P

rogr

am

–th

e si

ngle

larg

est,

long

est s

tand

ing

publ

ic/p

rivat

e pa

rtner

ship

of

its k

ind.

Mer

ck h

as p

rovi

ded

mor

e th

an 8

50 m

illion

tabl

ets

of

Mec

tizan

free,

goa

l is

to e

limin

ate

river

blin

dnes

s

•P

fizer

's D

ifluc

anP

artn

ersh

ip P

rogr

amm

e –

Pfiz

er d

onat

es D

ifluc

anto

org

anis

atio

ns in

sub

-Sah

aran

Afri

ca

and

leas

t dev

elop

ed c

ount

ries

•N

ovar

tis a

nd th

e N

ovar

tis F

ound

atio

n fo

r Sus

tain

able

D

evel

opm

ent,

in c

oope

ratio

n w

ith W

HO

,hav

e co

mm

itted

to

prov

ide

free

lepr

osy

treat

men

t for

all

lepr

osy

patie

nts

wor

ldw

ide

until

end

200

5

•G

SK

–H

ighl

ight

s in

clud

e do

natio

n of

94

mill

ion

treat

men

ts o

f al

bend

azol

eto

34

coun

tries

thro

ugh

partn

ersh

ip w

ith W

HO

in th

e G

loba

l Pro

gram

me

to e

limin

ate

Lym

phat

ic F

ilaria

sis

Exam

ples

of R

oche

Priv

ate

Publ

ic

Part

ners

hips

Don

ated

exp

ertis

e in

indu

stria

l dru

g de

velo

pmen

t and

m

alar

ia d

rug

deve

lopm

ent t

o M

MV

to s

uppo

rt O

Z277

–to

incr

ease

pac

e of

rese

arch

, dev

elop

men

t and

affo

rdab

ility

of

new

ant

imal

aria

lsan

d ne

w tr

eatm

ent s

trate

gies

•R

oche

don

ated

the

right

s an

d te

chno

logy

to

man

ufac

ture

Ben

zoni

dazo

le, f

or C

haga

sdi

seas

e, to

B

razi

lian

gove

rnm

ent i

n 20

03

•C

TAP

-col

labo

ratio

n to

incr

ease

acc

ess

to H

IV

treat

men

t in

Cam

bodi

a

•C

AR

E p

rogr

amm

e to

wid

en a

cces

s to

HIV

ther

apy

via

build

ing

up m

edic

al in

frast

ruct

ure

in 4

Afri

can

coun

tries

2004

-H

IV/A

IDS

trai

ning

for 1

40 A

fric

an h

ealth

care

pr

ofes

sion

als,

from

14

Afr

ican

cou

ntrie

s.

DVD

pro

duce

d to

ext

end

lear

ning

Dr.

Erne

st D

arko

h, o

pera

tiona

l man

ager

fo

r Bot

swan

a's

effo

rt to

exp

and

trea

tmen

t w

ith a

ntire

trov

iral d

rugs

Phel

ophe

pa “

The

Trai

n of

Hop

e” -

Clin

ic o

n tr

acks

Phel

ophe

pa –

A c

linic

on

trac

ks

•P

helo

phep

a w

as fo

unde

d in

199

3 by

Tra

nsne

tfol

low

ing

the

“Ear

th S

umm

it” in

Rio

in 1

992

•R

oche

has

bee

n a

spon

sor s

ince

199

4, to

geth

er w

ith

othe

r priv

ate

sect

or o

rgan

isat

ions

•Th

is tr

ain

prov

ides

bas

ic m

edic

al c

are

and

train

ing

to

mor

e th

an 1

80,0

00 in

divi

dual

s an

nual

ly in

rura

l are

as in

S

outh

Afri

ca

•P

eopl

e liv

ing

in th

ese

area

s do

not

hav

e ac

cess

to

med

ical

car

e ot

herw

ise

Cha

lleng

es a

head

•G

loba

l sca

le o

f HIV

/AID

S d

evas

tatio

n

•A

bilit

y to

pre

vent

/ re

duce

HIV

tran

smis

sion

•H

ow c

an “a

fford

abili

ty” o

f hea

lthca

re a

nd

med

icin

es b

e de

fined

?

•3

prio

rity

dise

ases

of t

he d

evel

opin

g w

orld

id

entif

ied

by W

HO

nee

d ev

er in

crea

sing

fund

ing:

H

IV/A

IDS

, TB

& M

alar

ia

•S

usta

ined

and

incr

ease

d –

polit

ical

will

–gl

obal

fund

ing

Sum

mar

y

•W

orld

wid

e th

ere

are

imm

ense

dis

parit

ies

of:

–In

com

e, fu

nctio

ning

hea

lthca

re s

yste

ms,

hea

lthca

re

fund

ing

and

polit

ical

will

•G

loba

l Fun

d, W

orld

Ban

k an

d P

EP

FAR

fund

ing

avai

labl

e

•S

igni

fican

t act

ions

by

phar

mac

eutic

al

com

pani

es d

esig

ned

to in

crea

se s

usta

inab

le

acce

ss to

hea

lthca

re a

nd m

edic

ines

•W

e ca

nnot

ach

ieve

this

alo

ne –

supp

ort n

eede

d fro

m a

ll ot

her s

take

hold

ers

to m

ove

forw

ard

Not

hing

mor

e w

ill re

ally

cha

nge

with

out:

•G

over

nmen

t lea

ders

hip

•Fu

ndin

g

•C

hang

ed b

ehav

iour

•A

dequ

ate

num

bers

of t

rain

ed h

ealth

care

pr

ofes

sion

als